This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,131.02 fixed-price delivery order is for the supply of 4,566,738,644 units of the pharmaceutical drug Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This delivery order is likely part of a broader procurement of essential medical commodities by the DLA to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/18/25, 9:46 AM